000 | 02113 a2200613 4500 | ||
---|---|---|---|
005 | 20250516043605.0 | ||
264 | 0 | _c20120628 | |
008 | 201206s 0 0 eng d | ||
022 | _a1873-3476 | ||
024 | 7 |
_a10.1016/j.ijpharm.2011.06.010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGautier, J | |
245 | 0 | 0 |
_aA pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting. _h[electronic resource] |
260 |
_bInternational journal of pharmaceutics _cFeb 2012 |
||
300 |
_a16-25 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 |
_aChlorides _xchemistry |
650 | 0 | 4 |
_aCytoplasm _xmetabolism |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
650 | 0 | 4 |
_aFerric Compounds _xchemistry |
650 | 0 | 4 |
_aFerrous Compounds _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aIsoelectric Point |
650 | 0 | 4 | _aLight |
650 | 0 | 4 |
_aMagnetics _xmethods |
650 | 0 | 4 |
_aMagnetite Nanoparticles _xchemistry |
650 | 0 | 4 | _aMicroscopy, Electron, Transmission |
650 | 0 | 4 |
_aMicroscopy, Fluorescence _xmethods |
650 | 0 | 4 |
_aNitrates _xchemistry |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
650 | 0 | 4 |
_aPropylamines _xchemistry |
650 | 0 | 4 | _aScattering, Radiation |
650 | 0 | 4 |
_aSilanes _xchemistry |
650 | 0 | 4 | _aStatic Electricity |
650 | 0 | 4 | _aSurface Properties |
700 | 1 | _aMunnier, E | |
700 | 1 | _aPaillard, A | |
700 | 1 | _aHervé, K | |
700 | 1 | _aDouziech-Eyrolles, L | |
700 | 1 | _aSoucé, M | |
700 | 1 | _aDubois, P | |
700 | 1 | _aChourpa, I | |
773 | 0 |
_tInternational journal of pharmaceutics _gvol. 423 _gno. 1 _gp. 16-25 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2011.06.010 _zAvailable from publisher's website |
999 |
_c20957140 _d20957140 |